FitnessGenes files first patent application
FitnessGenes is a digital health startup founded in 2013. Aimed at the recent growth in biohackers and individuals spending more money on fitness, the company uses DNA sampling to provide personalized training plans. In 2017, the company filed its first patent application, which was recently published. The activity component of the AI biotech sector has been dominated by wearables, so FitnessGenes’ application provides increased diversity.
The company underwent a $5 million Series A funding round in 2017 after a few seed rounds. They have multiple academic collaborations with UK universities such as Loughborough and Birmingham, as well as partnerships with other popular DNA testing companies including 23andMe and AncestryDNA

Related Posts
April 15, 2021
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
AI Biotech / Diagnostics,AI Biotech / Diagnostics: Activity,AI Biotech / Diagnostics: Neurology
April 8, 2021
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
April 1, 2021
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…
AI Biotech / Diagnostics,AI Biotech / Diagnostics: Neurology


